Robert H. Lurie Comprehensive Cancer Center and Division of Hematology-Oncology, Department of Medicine, Northwestern University Medical School, Chicago, Illinois 60611.
Toronto Research Institute, University Health Network and Department of Immunology, University of Toronto, Toronto, Ontario M5S 2J7, Canada.
J Biol Chem. 2014 Mar 7;289(10):6581-6591. doi: 10.1074/jbc.M113.537852. Epub 2014 Jan 27.
We provide evidence that type I IFN-induced STAT activation is diminished in cells with targeted disruption of the Rictor gene, whose protein product is a key element of mTOR complex 2. Our studies show that transient or stable knockdown of Rictor or Sin1 results in defects in activation of elements of the STAT pathway and reduced STAT-DNA binding complexes. This leads to decreased expression of several IFN-inducible genes that mediate important biological functions. Our studies also demonstrate that Rictor and Sin1 play essential roles in the generation of the suppressive effects of IFNα on malignant erythroid precursors from patients with myeloproliferative neoplasms. Altogether, these findings provide evidence for critical functions for Rictor/Sin1 complexes in type I IFN signaling and the generation of type I IFN antineoplastic responses.
我们提供的证据表明,在靶向敲除 Rictor 基因的细胞中,Ⅰ型干扰素诱导的 STAT 激活会减弱,而 Rictor 基因的蛋白产物是 mTOR 复合物 2 的关键组成部分。我们的研究表明,Rictor 或 Sin1 的瞬时或稳定敲低会导致 STAT 途径的组成部分激活缺陷,并减少 STAT-DNA 结合复合物。这会导致几种 IFN 诱导基因的表达减少,这些基因介导重要的生物学功能。我们的研究还表明,Rictor 和 Sin1 在 IFNα 对骨髓增生性肿瘤患者恶性红系前体细胞产生抑制作用中发挥重要作用。总之,这些发现为 Rictor/Sin1 复合物在Ⅰ型 IFN 信号转导和Ⅰ型 IFN 抗肿瘤反应的产生中的关键功能提供了证据。